QA: vTv Therapeutics Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001641489_2023_vTv_Therapeutics_Inc.pdf

Logs

Graph

Absolute values for 0001641489, vTv Therapeutics Inc

  xvar xval
0 AssetsCurrent 27,094,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 207,000
3 remainder_Assets 5,937,000
4 LiabilitiesCurrent 7,708,000
5 LiabilitiesNoncurrent 19,007,000
6 remainder_Liabilities 684,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,200,081
9 ResearchAndDevelopmentExpense 11,623,108
10 remainder_Expenses 185,954
11 remainder_Revenues 2,844,756
12 remainder_NetIncome 4,052,726
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 33,238,000
1 Liabilities 27,399,000
2 Expenses 24,009,143
3 Revenues 2,844,756
4 StockholdersEquity 5,839,000
5 NetIncome -17,111,661
6 ComprehensiveNetIncome -17,111,661
7 BaseVar 45,771,812
8 EconomicCapitalRatiobeforeLimitedLiability -0.145
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time